PROTAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Protamine patents expire, and when can generic versions of Protamine launch?
Protamine is a drug marketed by Pharmacia And Upjohn, Fresenius Kabi Usa, Hikma, and Lilly. and is included in five NDAs.
The generic ingredient in PROTAMINE is protamine sulfate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the protamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Protamine
A generic version of PROTAMINE was approved as protamine sulfate by FRESENIUS KABI USA on April 7th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROTAMINE?
- What are the global sales for PROTAMINE?
- What is Average Wholesale Price for PROTAMINE?
Summary for PROTAMINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for PROTAMINE |
| DailyMed Link: | PROTAMINE at DailyMed |
US Patents and Regulatory Information for PROTAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | PROTAMINE SULFATE | protamine sulfate | POWDER;INTRAVENOUS | 007413-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | PROTAMINE SULFATE | protamine sulfate | SOLUTION;INTRAVENOUS | 089475-001 | Nov 5, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | PROTAMINE SULFATE | protamine sulfate | SOLUTION;INTRAVENOUS | 089454-002 | Apr 7, 1987 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | PROTAMINE SULFATE | protamine sulfate | SOLUTION;INTRAVENOUS | 006460-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
